Meeting
2021 ASCO Annual Meeting
The prognostic impact of RAS and TP53 mutation according to primary tumor location in colorectal liver metastases.
Authors
Yongjun Cha
National Cancer Center, Goyang, South Korea
Yongjun Cha , Bun Kim , Seung Jae Roh , Moon Ki Choi , Dong Woon Lee , Sung-Sik Han , Seong Hoon Kim , Sang-Jae Park , Ji Yeon Baek , Sung Chan Park , Hee Jin Chang , Jae Hwan Oh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3582)
DOI
10.1200/JCO.2021.39.15_suppl.3582
Abstract #
3582
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical and genomic landscape of RAS pathway mutations in gynecologic cancers.
First Author: Ji Son
Poster
2017 ASCO Annual Meeting
Colorectal cancer: Impact of primary tumor location on genetic alterations.
First Author: Mohamed E. Salem
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2014 ASCO Annual Meeting
Molecular evaluation of primary tumor (PT) and synchronous liver metastasis in colorectal cancer (srLmCRC) patients after cetuximab-based chemotherapy.
First Author: Daniela Adua